Impact Factor
3.19
Journal Citation Impact
Estimated influence, citation density, publishing volume, and citation integrity from the analytics table.
Citation rate
2.26
486 total citations
h5-index
29
h5 depth signal
Cited share
61.0%
141 of 231
Total citations
486
Citation footprint
Metric signal
2.49
External metric anchor
Self-citation
1.2%
6 self-citations
Citations Trend
Monthly Publications Cadence
Citing Geographic Demographics
France
526
Italy
24
India
22
China
21
United States
18
Citing Fields of Research
Antibiotic & Antibacterial Agents
253
Virology
124
HIV
49
Tropical Diseases
40
Healthcare Policy
40
Publishing Activity & Reach
Volume, recency, access pattern, and citing-community signals from the journal analytics record.
All-time article footprint
1,011
Articles tracked across the journal lifetime
Indexed publication set
231
141 cited publications
Last 12 months
119
9.9 publications/month
Open access share
29.4%
35 OA publications in the last year
Leading citing country
France
526 citing publications
Leading citing field
Antibiotic & Antibacterial Agents
253 citing publications
Latest tracked publication
17 October 2026
10 recent records available
Coverage & Indexing History
v51n1, Feb. 2021-
v51n1, Feb. 2021-
Research Focus & Classification
Indexed Subjects
Antibiotic & Antibacterial Agents
Issuing & Sponsoring Bodies
sponsoring body
Société de pathologie infectieuse de langue française
Broad Categories
Communicable Diseases
Antibiotic & Antibacterial Agents
Virology
HIV
Sexually Transmitted Diseases
Digestive Disorders
MeSH Descriptors
Communicable Disease Control
Communicable Diseases
Latest Publications
Recent article records with DOI-first linking and condensed abstracts.
01
02
DOI 10.1016/j.idnow.2026.105375
Open DOI
Validating susceptibility reporting through treatment indication and diagnostic access
03
04
DOI 10.1016/s2666-9919(26)00121-1
Open DOI
Editorial board
05
DOI 10.1016/j.idnow.2026.105372
Open DOI
High burden of Carbapenem-resistant Enterobacterales: A prospective cross-sectional study at a tertiary hospital in Morocco
06
07
DOI 10.1016/j.idnow.2026.105370
Open DOI
Tick-borne diseases in French Guiana: A comprehensive review pinpointing differences from mainland France
08
DOI 10.1016/j.idnow.2026.105359
Open DOI
Classifying drug-related risks in aspiration pneumonia: The case for dopamine blockade
09
DOI 10.1016/j.idnow.2026.105361
Open DOI
The impact of pretreatment HBs-Ag levels on response to interferon therapy in chronic hepatitis D patients
10
Bibliographical & Catalog Notes
Official journal of the SPILF, French Infectious Diseases Society (Société de Pathologie Infectieuse de Langue Française).